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Abstract: Oxidized L-glutathione was esterified to the tetra methyl ester using thionyl 
chloride in methanol solvent. Other alcohols were tested and the reaction progress was 
monitored via ESI-MS. This procedure proved to be compatible with other small peptides 
not containing serine and cysteine residues. In contrast to previously reported methods this 
procedure provided convenient access to esterified peptides requiring no purification, 
extended reaction times, or complicated reaction setups. 
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1. Introduction 
The design and synthesis of novel glutathione analogues are studied extensively for their 
pharmacological properties in the treatment of a wide range of diseases [1–3]. Reduced glutathione 
(GSH), -L-glutamyl-L-cysteinyl-glycine, is prone to reactivity at the sulfhydryl, terminal amino group, 
and both carbonyls. Thus, the synthesis of GSH analogues are a synthetic challenge to chemists, and the 
clever manipulation of protecting groups are needed to prevent unwanted reactions. One approach to 
synthesize protected GSH analogues is to start with the readily available disulfide dimmer of GSH,  
L-glutathione (GSSG) 1. GSSG is affordable and the sulfhydryl functional groups are protected in their 
disulfide form. 1 can be inconveniently converted to 2a by Fischer esterification [4–6] resulting in the 
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protection of the carboxyl groups. In our hands the reported Fischer esterification protocol required 
extensive purification and the isolated yield was too low to be of practical value. Although 2a is 
commercially available the cost is quite high ($1290 per 100 mg) making direct purchase prohibitive in 
many cases [7]. Additional esterification strategies include utilizing trimethylsilyl chloride in methanol 
solvent [2,8] and the use of diazomethane to form methyl esters [9,10]. However, the use of diazomethane 
is toxic, potentially explosive, and requires specialized glassware not readily available in all labs.  
Herein, we report a convenient synthesis of 2a using thionyl chloride in methanol solvent as illustrated 
in Scheme 1. Surprisingly, this method eliminated side reactions, long reaction times, and column 
purification. Furthermore, we extended the method to other peptides in order to gain an understanding 
of the compatibility with other protogenic amino acids. The ease with which peptide esters are formed 
could be an invaluable tool for peptide mass spectrometry [3,11–13] as the protected carboxylic acid 




















































2c: R= CH(CH3)2  
Scheme1. Preparation of oxidized glutathione tetra-alkyl esters (GSSG(OR)4) from oxidized 
glutathione (GSSG) using thionyl chloride in alcohol solvent. 
2. Results and Discussion 
The esterification of oxidized glutathione (GSSG) with thionyl chloride was previously  
reported [14], but studies monitoring the reaction conversion have not been reported. The disposition 
toward thionyl chloride acylation is likely due to the incompatibilities often associated with the harsh 
conditions of thionyl chloride which are subject to both side reactions and incomplete formation of 
product. Therefore, we set out to study the limitations of this method by monitoring the reaction using 
ESI-MS in the presence of various alcohols using 1 as a substrate.  
The reactions were performed on 250 mg of GSSG in 50 mL of anhydrous alcohol. To this solution 
2.5 mL of thionyl chloride was added slowly and placed into a refrigerator at 4 °C. At various time 
intervals a 1.0 mL aliquot was taken, concentrated under reduced pressure, suspended into 1% acetic 
acid solution (50% methanol/water), and analyzed via ESI-MS. The relative intensities of the m/z for the 
tetra-ester were plotted as a percentage of ester products as illustrated in Figure 1. The procedure worked 
well in methanol solvent reaching completion within 16 h. The same experimental conditions were 
applied using an excess of anhydrous ethanol resulting in complete conversion to 2b in 144 h. In contrast, 
when the same experimental conditions were applied using an excess of anhydrous isopropyl alcohol 
only a 14% conversion to 2c was realized along with significant formation of various unidentified  
side products. We therefore concluded that studying other 2° or even 3° alcohols would likely not  
be productive. 




Figure 1. (a) Plot of the percent conversion to the GSSG tetra esters vs. time in methanol as 
determined by ESI-MS (b) Plot of the percent conversion to the GSSG tetra esters vs. time 
in ethanol as determined by ESI-MS.  
To further demonstrate the utility of this method the reaction conditions were applied to other small 
peptides as shown in Table 1. These peptides were chosen based on comparable size to GSSG and the 
coverage of amino acids present in their sequences. The reactions were performed on a 1.0 µmol scale 
and immediately concentrated following a 24 h incubation at 4 °C. The peptides were then immediately 
analyzed via ESI-MS.  









Estimated % c 
Conversion 
L-glutathione oxidized 2QCG b 2 Yes 100% d 
L-glutathione reduced QCG 3 No 26% 
Fibronectin Analog GRADSPK 4 No 23% 
Bradykinin (1–7) RPPGFSP 5 No 63% 
Necrofibrin, rat WTVPTA 6 No 64% 
[D-Ala2,D-Met5]-Enkephalin YAGFM 7 No 90% 
Angiotensin II, human DRVYIHPF 8 Yes 100% 
Thymopentin (TP-5) RKDVY 9 Yes 100% 
Neurotensin (9–13) RPYIL 10 Yes 100% 
[Ile3]-Pressinoic acid CYIQNC b 11 No 94% 
a Reaction conditions of the peptides were run using 3.44 M thionyl chloride in methanol at 4 °C for 24 h;  
b Peptide contains a disulfide bridge between the two cysteine residues; c Yields estimated by taking the sum 
or relative intensities of all product peaks over the total relative intensities observed in ESI-MS in excess of 
5% relative abundance; d isolated product yield. 
The reactions listed in Table 1 proceeded smoothly under the esterification protocol in most cases. 
However, the peptides containing serine, fibronectin and bradykinin, appear to have been converted to 
the esterified alkyl chloride derivative at the serine residue [15–17]. This is evidenced by the m/z 
corresponding to the molecular formula of the esterified peptide with chlorine replacing the hydroxyl 
functional group and the signature isotopic ratio of chlorine. These results are not unexpected 
considering that thionyl chloride is used to transform primary alcohols into alkyl chlorides. However, 
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we did observe the esterified product containing the unaltered serine residue as a minor constituent in 
the product mixture. Interestingly, the threonine containing peptide, necrofibrin, underwent smooth 
conversion to the ester without converting the 2° alcohol into an alkyl chloride. The phenol functional 
group of tyrosine in [DAla2,DMet5]-Enkephalin, Angiotensin II, Thymopentin (TP-5), and Neurotensin 
(9–13) did not interfere with the esterification procedure. 
The free sulfhydryl of the cysteine residue also proved to be problematic when subjected to the 
esterification protocol. Reduced L-glutathione was subjected to the reaction conditions producing the 
desired esterified peptide as a minor constituent. The reaction mixture contained significant quantities 
of 2 and several other unidentified species by ESI-MS analysis. However, the methionine residue of 
Enkephalin and the disulfide bond of [Ile3]-Pressinoic acid and GSSG were cleanly converted to their 
respective esters. In addition, the residues of aspartic acid and glutamic acid were converted to their 
respective methyl esters as expected. Despite these limitations all of the other protogenic amino acids 
withstood the reaction conditions and were easily isolated and characterized without the need for 
extensive purification.  
3. Experimental Section  
3.1. General Experimental  
NMR spectra were acquired on a Bruker 400 MHz NMR in proton decoupled mode. The internal 
standard used in the NMR experiment was the residual solvent signal for CD3OD. ESI MS was carried 
out on a ThermoFisher LXQ ESI-Ion trap mass spectrometer using Optima LCMS grade methanol and 
water from Fisher Scientific. The methanol used for the esterification reactions was distilled from 
calcium hydride, absolute ethanol was stored over molecular sieves, and 2-propanol distilled from 
sodium prior to use. L-oxidized glutathione and reduced glutathione were obtained from Sigma-Aldrich. 
All other peptides were acquired from the American Peptide Company and used as received. Peptides 
furnished with Certificate of Analysis (COA) contained trace impurities and those masses were provided 
courtesy of American Peptide Company. Mass spectra and NMR spectra can be found in the 
supplementary materials section. 
3.2. Synthesis of GSSG and GSH Peptides in Alcohol Solutions  
3.2.1. Synthesis of Compound 2 
In a 125 mL Erlenmeyer flask, 0.250 g of L-oxidized glutathione (0.408 mmol) was added to 50 mL 
of freshly distilled methanol and capped with a rubber septum. The contents were placed into an ice bath 
and allowed to cool to 0 °C. The addition of 2.5 mL of thionyl chloride (34.4 mmol) was by syringe, the 
flask was swirled, and placed into a refrigerator at 4 °C. After 24 h the reaction was concentrated under 
reduced pressure resulting in 0.272 g of product (100% yield).The product was analyzed via ESI MS. 
ESI MS of [M + H]+ calculated [C24H44N6O12S2]+, 669.22, found 669.2. 1H-NMR (400MHz, CD3OD)  
δ = 4.67 (m, 2H), 4.05 (m, 2H), 3.88 (s, 4H), 3.76 (s, 6H), 3.62 (s, 6H), 3.21 (s, 4H), 2.93–2.81 (m, 2H), 
2.49 (m, 4H), 2.12 (m, 4H) and 13C-NMR (100MHz, CD3OD) δ = 174.3, 173.0, 171.6, 170.7, 54.0, 53.9, 
53.7, 52.8, 42.0, 41.4, 32.3, 27.0. Spectra are consistent with published data [18]. 
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3.2.2. Synthesis of Compound 2b 
In a 125 mL Erlenmeyer flask, 0.250 g of L-oxidized glutathione (0.408 mmol) was added to 50 mL 
of absolute ethanol and capped with a rubber septum. The contents were placed into an ice bath and 
allowed to cool to 0 °C. The addition of 2.5 mL of thionyl chloride (34.4 mmol) was by syringe, the 
flask was swirled, and placed into a refrigerator at 4 °C. After 24 h the reaction was concentrated under 
reduced pressure resulting in 0.295 g of product (100% yield). The solid was taken and characterized by 
ESI-MS. ESI-MS of [M + H]+ calculated [C28H44N6O12S2]+, 725.28, found 725.25. 1H-NMR (400 MHz, 
CD3OD) δ = (400 MHz, MeOD) δ 4.78 (dd, J = 9.6, 4.6 Hz, 2H), 4.33 (q, J = 7.1 Hz, 4H), 4.19 (q,  
J = 7.1 Hz, 4H),4.13(m, 2H), 3.97 (d, J = 2.2 Hz, 4H), 3.28 (dd, J = 14.0, 4.6 Hz, 2H), 2.99 (dd, J = 13.9, 
9.7 Hz, 2H), 2.61 (t, J = 7.1 Hz, 4H), 2.23 (m, J = 21.7, 14.6, 7.5 Hz, 4H), 1.35 (t, J = 7.1 Hz, 6H), 1.28 
(t, J = 7.2 Hz, 6H).13C-NMR (100MHz, CD3OD) δ =174.4, 173.0, 171.1, 170.2, 63.4,62.4, 53.9,53.7, 
42.1, 41.3, 32.6, 27.0, 14.5, 14.43. Spectra are consistent with published data [19]. 
3.2.3. Synthesis of Compound 2c 
In a 125 mL Erlenmeyer flask, 0.250 g of L-oxidized glutathione (0.408 mmol) was added to 50 mL 
of freshly distilled 2-propanol and capped with a rubber septum. The contents were placed onto an ice 
bath and allowed to cool to 0 °C. The addition of 2.5 mL of thionyl chloride (34.4 mmol) was by syringe, 
and the flask was swirled and placed into a refrigerator at 4 °C. After 24 h the reaction was concentrated 
under reduced pressure. The resulting solid was taken and characterized by ESI-MS. ESI-MS of  
[M + H]+ calculated [C32H57N6O12S2]+, 781.35, found 781.25. Expected mass not present in significant 
quantities so no NMR data was recorded.  
3.2.4. Synthesis of Compound 3 
In a 125 mL Erlenmeyer flask, 0.250 g of L-reduced glutathione (0.813 mmol) was added to 50 mL 
of freshly distilled anhydrous methanol and capped with a rubber septum. The contents were placed onto 
an ice bath and allowed to cool to 0 °C. The addition of 2.5 mL of thionyl chloride (34.4 mmol) was by 
syringe, and the flask was swirled and placed into a refrigerator at 4 °C. After 24 h the reaction was 
concentrated under reduced pressure. The resulting solid was taken and characterized by ESI-MS.  
ESI-MS of [M + H]+ calculated [C12H22N3O6S]+, 336.12, found 336.08. Sample contained multiple 
impurities so no NMR analysis was performed. 
3.3. General Synthesis of Peptides in Methanol Solutions  
The conditions for each peptide were scaled down from the GSSG reaction study in methanol based 
on the number of carboxylic acid groups present in the molecule. The amount of methanol used in the 
reaction was 756 equivalents of methanol to which 105 equivalents of thionyl chloride was added for 
each carboxylic acid present in the peptide. This results in a 3.44 M solution of thionyl chloride in 
methanol. All reactions were performed on 1.0 mg of peptide and incubated at 4 °C for 24 h. At the end 
of the incubation the crude material was concentrated and analyzed by ESI-MS. 
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3.3.1. Synthesis of Compound 4 
In a dry glass vial fitted with a cap 1.0 mg of Fibronectin (1 µmol) was dissolved into 83.9 µL of 
anhydrous methanol (2.075 mmol) and placed in an ice bath at 0 °C. To the solution 21.0 µL of thionyl 
chloride (0.289 mmol) was added slowly via syringe. The vial was shaken and placed into a refrigerator 
at 4 °C. After 24 h the sample was concentrated under reduced pressure, dissolved into 1.0 mL of 1% 
acetic acid in a 1:1 solution of methanol:water, and analyzed on the ESI-MS. ESI-MS of [M + H]+ 
calculated [C31H56N11O11]+, 758.42, found 758.42. 
3.3.2. Synthesis of Compound 5 
In a dry glass vial fitted with a cap 1.0 mg of Bradykinin (1 µmol) was dissolved into 40.5 µL of 
anhydrous methanol and placed in an ice bath at 0 °C. To the solution 10.1 µL of thionyl chloride  
(0.14 mmol) was added slowly via syringe. The vial was shaken and placed into the fridge at 4 °C. After 
24 h the sample was concentrated under reduced pressure, dissolved into 1.0 mL of 1% acetic acid in a 
1:1 solution of methanol:water, and analyzed on the ESI-MS. ESI-MS of [M + H]+ calculated 
[C36H55N10O9]+, 771.41, found 771.38.  
3.3.3. Synthesis of Compound 6 
In a dry glass vial fitted with a cap 1.0 mg of necrofibrin, rat (1 µmol) was dissolved into 45.5 µL of 
anhydrous methanol (1.12 mmol) and placed in an ice bath at 0 °C. To the solution 11.4 µL of thionyl 
chloride (0.156 mmol) was added slowly via syringe. The vial was shaken and placed into a refrigerator 
at 4 °C. After 24 h the sample was concentrated under reduced pressure, dissolved into 1.0 mL of 1% 
acetic acid in a 1:1 solution of methanol:water, and analyzed on the ESI-MS. ESI-MS of [M + H]+ 
calculated [C33H50N7O9]+, 688.37; found 688.20. 
3.3.4. Synthesis of Compound 7 
In a dry glass vial fitted with a cap 1.0 mg of [DAla2,DMet5] Enkephalin (2 µmol) was dissolved 
into 52.1 µL of anhydrous methanol (1.29 mmol) and placed in an ice bath at 0 °C. To the solution  
13.0 µL of thionyl chloride (0.18 mmol) was slowly added via syringe. The vial was shaken and placed 
into a refrigerator at 4 °C. After 24 h the sample was concentrated under reduced pressure, dissolved 
into 1.0 mL of 1% acetic acid in a 1:1 solution of methanol:water, and analyzed on the ESI-MS.  
ESI-MS of [M + H]+ calculated [C29H40N5O7S]+, 602.26, found 602.1.  
3.3.5. Synthesis of Compound 8 
In a dry glass vial fitted with a cap 1.0 mg of angiotensin II, human (1 µmol) was dissolved into  
58.6 µL of anhydrous methanol (1.45 mmol) and placed in an ice bath at 0 °C. To the solution 14.6 µL 
of thionyl chloride (0.20 mmol) was added slowly via syringe. The vial was shaken and placed into a 
refrigerator at 4 °C. After 24 h the sample was concentrated under reduced pressure, dissolved into  
1.0 mL of 1% acetic acid in a 1:1 solution of methanol:water, and analyzed on the ESI-MS. ESI-MS of 
[M + H]+ calculated [C52H76N13O12]+, 1074.57, found 1074.6.  
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3.3.6. Synthesis of Compound 9 
In a dry glass vial fitted with a cap 1.0 mg of Thymopentin (TP-5) (1 µmol) was dissolved into  
90.1 µL of anhydrous methanol (2.22 mmol) and placed in an ice bath at 0 °C. To the solution 22.5 µL 
of thionyl chloride (0.289 mmol) was added slowly via syringe. The vial was shaken and placed into the 
fridge at 4 °C. After 24 h the sample was concentrated under reduced pressure, dissolved into 1.0 mL of 
1% acetic acid in a 1:1 solution of methanol:water, and analyzed on the ESI-MS. ESI-MS of [M + H]+ 
calculated [C32H54N9O9]+, 708.40, found 708.47. Masses present in starting material from COA: 
341(14%), 680 (100%), 1358(8%). 
3.3.7. Synthesis of Compound 10 
In a dry glass vial fitted with a cap 1.0 mg of Thymopentin (TP-5) (1 µmol) was dissolved into  
90.1 µL of anhydrous methanol (2.22 mmol) and placed in an ice bath at 0 °C. To the solution 22.5 µL 
of thionyl chloride (0.289 mmol) was added slowly via syringe. The vial was shaken and placed into the 
fridge at 4 °C. After 24 h the sample was concentrated under reduced pressure, dissolved into 1.0 mL of 
1% acetic acid in a 1:1 solution of methanol:water, and analyzed on the ESI-MS. ESI-MS of  
[M + H]+ calculated [C32H54N9O9]+, 708.40, found 708.47.  
3.3.8. Synthesis of Compound 11 
In a dry glass vial fitted with a cap 1.0 mg of [Ile3] Pressinoic Acid (1 µmol) was dissolved into  
41.3 µL of anhydrous methanol (1.02 mmol) and placed in an ice bath at 0 °C. To the solution 10.3 µL 
of thionyl chloride (0.14 mmol) was added slowly via syringe. The vial was shaken and placed into a 
refrigerator at 4 °C. After 24 h the sample was concentrated under reduced pressure, dissolved into  
1.0 mL of 1% acetic acid in a 1:1 solution of methanol:water, and analyzed on the ESI-MS. ESI-MS of 
[M + H]+ calculated [C31H47N8O10S2 ]+,755.29, found 755.22.  
4. Conclusions  
We have prepared GSSG methyl esters in high yield requiring no purification or complex reaction 
protocols. The title compound could also be prepared as the ethyl ester at the expense of increased 
reaction time. Based on these findings the reaction conditions were applied to other small peptides and 
found to be highly compatible with many peptide sequences. We believe this procedure will find 
significant use in the area of peptide modification for both synthetic and analytical purposes. 
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Supplementary materials can be accessed at: http://www.mdpi.com/1420-3049/20/06/10487/s1. 
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